Alla Grigorian — University of Kentucky

If you made any changes in Pure these will be visible here soon.

Education/Academic qualification

Residency, Univ Of Kentucky

2006

Doctor of Philosophy, Other Institution

1998

Doctor of Medicine, Yerevan State Medical Institute

1995

3 Finished
3 Active

A Randomised, Double-blind, Placebo-controlled, Multicentre, Phase 3 Study Evaluating Long-term Efficacy and Safety of Lanifibranor in Adult Patients with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) and Fibrosis 2 (F2)/Fibrosis 3 (F3) Stage of Live
Grigorian, A.
Pharmaceutical Research Associates
1/31/22 → 3/21/23
Project: Research project
The Role of Crypt Fissioning in IBD Ulcer Healing
Barrett, T., Beyer, R., Chaiswing, L., Flomenhoft, D., Gao, T., Goretsky, T., Harrison, D., Kapur, N., Lohr, K., Stromberg, A., Sullivan, P., Grigorian, A., Holt, E. & Liu, J.
National Institute Diabetes & Digestive & Kidney
2/24/21 → 1/31/25
Project: Research project
A Phase 3, Double-Blind, Randomized, Long Term, Placebo-Controlled Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis
Grigorian, A. & Leyson, C.
Intercept Pharmaceuticals Incorporated
3/15/16 → 8/8/23
Project: Research project
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis GS-US-384-1943
Grigorian, A.
Gilead Sciences Inc
8/1/17 → 8/31/18
Project: Research project
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) GS-US-384-1944
Grigorian, A. & Leyson, C.
Gilead Sciences Inc
8/1/17 → 8/31/18
Project: Research project